Skip to main content
. 2022 Mar 16;13:813732. doi: 10.3389/fimmu.2022.813732

Figure 1.

Figure 1

Association of several factors with progression-free survival in patients treated with PD-1 inhibitor. Association of (A) CPS level. (CPS, combined positive score), (B) 11q13 amplification status. (11q13: CCND1_FGF3_FGF4_FGF19 or any one of them), (C) EGFR amplification status, or (D) EGFR mutation status, with progression-free survival. *p<0.05.